Current status of immunotherapy for sarcomas.
Sign Up to like & getrecommendations! Published in 2017 at "Immunotherapy"
DOI: 10.2217/imt-2017-0101
Abstract: Although the development of anticancer drugs has improved the outcomes of bone and soft tissue sarcomas, the clinical outcome of patients with relapsed sarcomas remains unsatisfactory due to therapeutic toxicities and resistance to anticancer drugs.… read more here.
Keywords: immunotherapy; current status; immunotherapy sarcomas; status immunotherapy ... See more keywords